From: Evaluation of lung involvement in COVID-19 pneumonia based on ultrasound images
Method | S (%) | S&M (%) | S&M&P (%) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Acc | PP | Se | Sp | Acc | PP | Se | Sp | Acc | PP | Se | Sp | |
Method comparison | ||||||||||||
 VGG [20] | 93.15 | 73.07 | 74.62 | 96.09 | 89.87 | 76.36 | 73.05 | 94.06 | 88.81 | 73.5 | 67.37 | 93.19 |
 ResNet [21] | 93.19 | 73.56 | 75.55 | 96.06 | 90.63 | 77.77 | 74.94 | 94.51 | 89.41 | 74.56 | 68.78 | 93.56 |
 ResNeXt (baseline) [22] | 93.15 | 77.82 | 74.62 | 96.31 | 91.7 | 79.98 | 77.57 | 94.94 | 90.46 | 75.92 | 70.9 | 94.04 |
 SENet-50 [23] | 92.5 | 72.16 | 73.33 | 95.65 | 93.64 | 83.16 | 83.74 | 96.28 | 92.37 | 79.71 | 75.93 | 95.33 |
 SKNet-50 [24] | 92.8 | 86.32 | 76.97 | 95.79 | 92.12 | 80.45 | 78.63 | 95.4 | 91.03 | 77.21 | 72.55 | 94.55 |
Ablation experiment | ||||||||||||
 w/o. CRFA and w/o. fusion module | 93.15 | 77.82 | 74.62 | 96.31 | 91.7 | 79.98 | 77.57 | 94.94 | 90.46 | 75.92 | 70.9 | 94.04 |
 w/o. CRFA module | 93.19 | 78.09 | 75.55 | 96.34 | 92.12 | 81.21 | 78.63 | 95.17 | 90.93 | 77.14 | 71.94 | 94.3 |
 MCRFNet | 97.73 | 85.72 | 88.06 | 98.69 | 96.25 | 87.2 | 83.59 | 97.74 | 94.39 | 82.28 | 76.27 | 96.44 |